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Abstract
Current cloning technologies based on site-specific recombination are efficient, simple to use, and flexible, but have the
drawback of leaving recombination site sequences in the final construct, adding an extra 8 to 13 amino acids to the
expressed protein. We have devised a simple and rapid subcloning strategy to transfer any DNA fragment of interest from
an entry clone into an expression vector, without this shortcoming. The strategy is based on the use of type IIs restriction
enzymes, which cut outside of their recognition sequence. With proper design of the cleavage sites, two fragments cut by
type IIs restriction enzymes can be ligated into a product lacking the original restriction site. Based on this property, a
cloning strategy called ‘Golden Gate’ cloning was devised that allows to obtain in one tube and one step close to one
hundred percent correct recombinant plasmids after just a 5 minute restriction-ligation. This method is therefore as efficient
as currently used recombination-based cloning technologies but yields recombinant plasmids that do not contain
unwanted sequences in the final construct, thus providing precision for this fundamental process of genetic manipulation.
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Introduction
Genome-scale expression of complete sets of ORFs requires
efficient and high-throughput cloning methods. At present, several
technologies are being used that are based on site-specific
recombination systems, such as the Gateway system from
Invitrogen, the Creator cloning system from Clontech and the
Univector cloning system developed by the lab of Stephen Elledge
(reviewed in [1]). These technologies are efficient, simple to use,
and flexible since user-specific vectors can easily be converted to
be compatible with the entry clones. However, one limitation of
these systems is that recombination site sequences are left in the
final construct, adding 8 extra aminoacids for the attB recombi-
nation site or 11 aminoacids for the LoxP site (if these sites are
located in expressed sequences). It is possible to eliminate the
recombination sites from the final expressed protein by flanking
them with intron sequences [2,3]. This solution is however valid
only for expression protocols that rely on eukaryotic cells.
Moreover, the use of splicing requires checking for the presence
of potential splice sites in expressed sequences near the artificial
splice site to avoid unwanted alternative splicing events. Finally,
the presence of intron sequences flanking the recombination sites
means that the same library of ORFs might not be compatible
with different expression systems. One other limitation of
recombination-based systems is that they require the purchase of
commercial kits or kit components, which can represent a
significant cost when working with large gene sets.
We have developed an alternative subcloning strategy that is not
based on site-specific recombination but relies on the use of type
IIs restriction enzymes. Type IIs restriction enzymes are able to
cleave DNA outside of their recognition site, resulting in 59 or 39
DNA overhangs (depending on the enzyme) that can consist of any
nucleotide. Therefore, 256 different overhangs can be created
using a type IIs restriction endonuclease that produces a 4 nt
overhang. This property has been used to develop protocols for
efficient assembly of multiple DNA fragments in a single ligation
reaction, for mutagenesis, and for cloning of fragments with
seamless junctions [4,5,6,7,8] (for reviews [9,10,11]). With proper
design of the cleavage sites, two digested fragments can be ligated
to generate a product lacking the original restriction site. This
property has been used to design a strategy for sequential assembly
of pre-made modules [12], or to replace the two steps of digestion
and ligation by a single restriction-ligation step [13]. We have
taken advantage of the various properties of type IIs restriction
enzymes to design a method that allows subcloning in a single step
and a single tube, and close to 100% efficiency a DNA fragment
from an entry clone into an expression construct, without adding
any additional nucleotide sequences to the final cloned product.
Results
Since one of the goals of our lab is to express recombinant
proteins (using plant viral vectors), we often need to clone specific
genes of interest in several expression vectors [14]. In order to
have a general subcloning strategy that does not depend on the
sequence of each specific gene of interest, we design the gene of
interest to be flanked by BsaI sites in such a way that the
recognition sites of the enzyme are located on the outside of the
fragment relative to the cleavage site (Fig 1, plasmid A). This has
multiple advantages: (1) the enzyme recognition site is independent
from the sequence of the gene of interest and will be eliminated
after subcloning, (2) allowing restriction and ligation to be
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have different cleavage site sequences, allowing directional cloning
and preventing religation of empty vector, (4) the 4 nucleotide
overhangs can be designed to be non-palindromic, rendering
cloning very efficient since each DNA fragment becomes unable to
ligate to another copy of the same molecule, (5) there is no buffer
incompatibility issues since only one restriction enzyme is used for
both cleavage sites. The recipient expression vector contains two
BsaI restriction sites complementary with the restriction sites from
the entry clone (Fig 1, plasmid B). The two BsaI sites flank a LacZ
alpha fragment and are positioned such that the recognition sites
are eliminated from the vector after digestion. The expression
vector has a kanamycin resistance gene, while the entry vector
contains the beta-lactamase gene providing carbenicillin resis-
tance. Digestion with BsaI of a mix of the two constructs leads to 4
fragments that can religate into 4 different possible plasmids. The
power of this system comes from the fact that the only stable
product issued from a restriction-ligation is the desired recombi-
nant plasmid, while all other combinations are substrate for BsaI
redigestion.
Subcloning from one entry clone to one expression
vector
Two constructs were made according to the above description.
The entry vector contains a GFP gene flanked by two BsaI sites,
with the sequences aggt and gctt (1234 and 5678 respectively, in
Fig 1) at the cleavage sites (Fig 2A). The expression vector is based
on tobacco mosaic virus (it contains the 39 half of a TMV-based
vector [2]) and has two BsaI sites compatible with the entry clone.
To test the one-step subcloning strategy 50 ng of each uncut
plasmid was added to a single tube together with 2.5 units BsaI
enzyme and 2.25 units of T4 DNA ligase, in restriction-ligation
buffer in a final volume of 10 ml. Several buffers were tested,
including the ligase buffer from Promega (106: 300 mM Tris-HCl
pH 7.8, 100 mM MgCl2, 100 mM DTT, 10 mM ATP), and the
New England Biolabs buffer 3 (106: 500 mM Tris-HCl pH 7.9,
100 mM MgCl2, 1000 mM NaCl, 10 mM DTT) complemented
with 10 mM ATP (106concentration). The mix was incubated in a
water bath at 37uC for 5 to 30 min, and immediately transformed
into 100 ml of chemically competent E.coli cells. 500 mlo fL B
medium was added to the transformed cells, and 25 ml of this plated
on LB mediumcontainingkanamycinand X-Gal. We also tested an
alternative procedure for performing the restriction-ligation by
using a thermocycler with the following program: 5, 10, 20 or
30 minutes incubation at 37uC followed by 5 minutes at 50uC and
then 5 minutes at 80uC. The incubation at 50uC was performed to
redigest and eliminate any plasmid that might still contain a BsaI
restriction site, while the 80uC incubation was aimed at inactivating
both restriction enzyme and ligase. For all four transformations,
both the ratio and the absolute number of white colonies increased
from 5 to 30 minutes (Table 1). On average, more white colonies
were obtained when the restriction-ligation was performed in
ligation buffer, and especially when the restriction-ligation was
followed by digestion and heat inactivation; it is possible that while
raising the temperature to 50uC, more efficient ligation for a short
amount of time results in a few more positive constructs.
Interestingly, a 5 minute restriction-ligation was sufficient for all
experiments to get a majority of white colonies.
For all 4 treatments, 6 white colonies from the 5 and 10 minutes
time points were picked and inoculated in 5 ml of LB medium.
Analysis of miniprep DNA by restriction digest (using two enzymes
other than BsaI,since it is not presentin the final construct) revealed
that all 48 colonies contained the desired construct (Fig 2B). It is
theoreticallypossible that oneof the recombinant plasmids obtained
might consist of a dimer made of two vectors and two inserts ligated
in tandem (vector-insert-vector-insert). To test this possibility,
undigested DNA was analyzed by gel electrophoresis. All 48
minipreps had the same migration pattern indicating that none was
a dimer (not shown). The insert region of 32 minipreps was then
sequenced; all plasmids were found to have the expected inserts,
with correct sequence at the cloning junction sites.
Therefore, we can conclude that a 5 minutes restriction-ligation
in a single tube performed in a water bath or a thermocycler is
sufficient to obtain the desired construct. Incubation for longer
Figure 1. Cloning strategy. Entry clone (A) and expression vector (B)
are mixed in one tube together with BsaI and ligase. Of the 4 possible
ligation products, A to D, only the desired product, D, is stable, while all
others are redigested with BsaI. Numbers 1 to 8 denote any nucleotide
of choice, and numbers in italics denote the complementary
nucleotides. FOI, DNA fragment of interest.
doi:10.1371/journal.pone.0003647.g001
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containing the desired construct, but is not necessary. Although
the optimal digestion temperature of BsaI is 50uC, it appears that
37uC is suitable for efficient restriction-ligation. Moreover, we can
see that about 50% of all plasmid DNA present in the ligated mix
is converted into the desired recombinant plasmid in just a
30 minute restriction-ligation.
Subcloning from multiple entry clones to one expression
vector
Considering the extremely high efficiency of the one tube
protocol, it was logical to test whether several fragments could be
subcloned in one tube one step. For this purpose 4 new entry
clones, pE-GFP2, pE-H, pE-S and pE-GFP3 were made to test
construction of expression vectors from two or three insert
fragments (Fig 3). These modules allow making GFP constructs
with or without a signal peptide and/or a His tag Restriction-
ligations were performed using the optimal conditions defined
previously (Promega ligation buffer, and restriction-ligation
followed by heat inactivation). Restriction-ligations were set up
as described above, using 50 ng of cloning vector and 50 ng of
each entry clone in a 10 ml reaction. The one-insert cloning was
repeated as a control. After restriction-ligation, 5 ml of the reaction
mix was transformed into 50 ml of chemically competent cells.
500 ml of LB were added to the cells after heat shock, then the cells
left to recover for 30 minutes at 37uC, and then 25 ml of the
resulting mix plated. For all cloning experiments, the absolute and
the relative number of white colonies increased from 5 to
30 minutes (Table 2). The number of colonies obtained with the
one insert control was lower than in the first experiment, but this
reflects the fact that a lower amount of DNA was transformed in
E.coli, and that different batches of competent cells were used. The
zero minute control however provides a reference for the amount
of DNA and the competency of the cells. As expected, more inserts
led to a smaller number of white colonies, but since a plateau was
not reached at 30 minutes, it is likely that more colonies would be
obtained by a longer incubation. Twelve minipreps were prepared
from white colonies, for the two and three inserts experiments. All
twelve colonies contained the expected insert. The insert regions of
32 white colonies for the two and three inserts cloning experiments
were sequenced; all 64 sequences were found to be correct at all
junction sites.
This shows that the one step one tube cloning protocol also
allows cloning of at least three inserts with extremely high
efficiency.
Figure 2. Subcloning of one insert into an expression vector.
(A) Maps of entry clone pE-GFP, expression cloning vector pX-lacZ and
expression construct pX-GFP. Black arrows show the position of the
restriction sites for the enzymes BseRI and HindIII, and the numbers
next to these indicate the sizes of the restriction fragments obtained.
The grey triangle represents a Streptomyces phage C31 attB recombi-
nation site (this site is not used for the cloning procedure described
here). Z, LacZ alpha fragment; N, Viral 39 Non-translated region; T, Nos
terminator; RB/LB, T-DNA right/left borders; S1–S2, selectable markers 1
and 2 (resistance to carbenicillin and kanamycin, respectively). (B)
Plasmid DNA from 48 white colonies and vector digested by BseRI and
HindIII and run on a 1% agarose gel. The upper and lower panels show
minipreps obtained from cloning performed using ligation buffer or
NEB buffer 3, respectively. DNA from all white colonies has the
restriction pattern of pX-GFP (the 119 bp fragment is too faint to be
visible on the picture). M: GeneRuler 1kb DNA Ladder Plus from
Fermentas. V, vector pX-lacZ.
doi:10.1371/journal.pone.0003647.g002
Table 1. Efficiency of cloning of pX-GFP at different restriction-ligation times.
106buffer
Digest and heat
inactivation
0 min* (white/
blue) 5 min (white/blue)
10 min (white/
blue)
20 min (white/
blue)
30 min (white/
blue)
Promega Lig buffer no 0/2653 155/13 215/4 665/1 881/0
Promega Lig buffer yes 0/3324 364/6 1283/4 1615/1 1820/1
NEB 3+10 mM ATP no 0/3660 30/9 50/3 139/1 335/11
NEB 3+10 mM ATP yes 0/3208 23/4 152/3 395/1 779/4
Restriction/ligations were performed from 5 to 30 minutes, and either immediately transformed in E.coli (Digest an heat inactivation/no) or incubated 5 minutes at 50uC
and 5 minutes at 80uC (Digest an heat inactivation/yes) before transformation in E.coli.
*The zero minute time point was performed without adding BsaI to the restriction-ligation mix.
doi:10.1371/journal.pone.0003647.t001
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One limitation of this cloning protocol might come from the
occasional presence of one or several internal BsaI site(s) in the
gene of interest, which would prevent the use of this strategy. A
general solution to this problem consists of eliminating any internal
BsaI restriction site from the fragment of interest upon cloning of
the entry clone. This can easily be done by designing primers
overlapping the internal BsaI site(s), but containing a single
nucleotide mismatch (a silent mutation is always possible) to
eliminate the BsaI recognition sequence (Fig 4). All PCR
fragments can be easily subcloned in one tube into a specially-
designed vector. Such cloning requires performing the BsaI
digestion first (or a restriction-ligation), then inactivating the BsaI
enzyme by heat inactivation, and then performing the ligation. All
white colonies should theoretically contain the desired construct
(provided that the template used for PCR amplification of the
fragments is not a plasmid with the same antibiotic resistance as
the cloning vector). To test this strategy, we made an entry clone
for the Arabidopsis thaliana chloroplast gene ycf4 (GenBank
NC_000932), which contains two internal BsaI sites. Six primers
were made, two primers flanking the ORF (ycf1: ttt ggtctc
aaggtatgagttggcgatcagaatc, and ycf6: ttt ggtctc a aagcttaaaatactt-
caattggtacacgcaag, each adding an external BsaI site compatible
with the entry cloning vector), and 4 primers overlapping the
internal BsaI sites (ycf2: ttt ggtctc a atcccgttataaattctatccatatag,
ycf3: ttt ggtctc a ggatctcgaaaaacaagtaatttctgctgg, ycf4: ttt ggtctc a
acagacctgcgatcccatagaaag, and ycf5: ttt ggtctc a ctgtttattagttgc-
tatttgtggtgcac, see Fig 5). 3 PCR fragments were amplified from
Arabidopsis thaliana genomic DNA. All three PCR products were
purified with a column (NucleoSpin Extract II, Macherey-Nagel,
Du ¨ren, Germany). A restriction digest was set up with 50 ng of
each of the three purified products, 200 ng undigested entry
cloning vector pECV, Promega ligation buffer, 10 U (0.5 ml) BsaI
enzyme in a 20 ml volume, and was incubated 30 min at 37uC,
followed by 10 min at 80uC. 1.5 ml (4.5 U) of ligase was then
added and the mix incubated 30 min at 20uC. 20 ml was
transformed in 100 ml of competent cells. Restriction analysis of
10 randomly chosen white colonies indicates that all had the
expected structure. Four colonies were sequenced and were found
to have the expected insert. One of these clones had one
nucleotide polymorphism in the sequence overlapping with one of
the primers used for amplification (mutation derived from the
primer and not the cloning strategy), one clone had a PCR-
induced mutation, and two clones had the correct sequence.
An entry clone was also made for a second (larger) gene that
contains a single internal BsaI site (chloroplast gene psbC, GenBank
NC_000932, primers ps1: ttt ggtctc a aggtatgaaaaccttatattccctgag-
gagg, ps2: ttt ggtctc a tcgcgaactagaaaagtaaatgcttgag, ps3: ttt ggtctc a
Figure 3. Subcloning of 2 and 3 inserts into an expression
vector. (A–C) Maps of expression cloning vector pX-lacZ (A), and of
entry clones and the resulting constructs for 2 or 3 insert cloning
experiments (B, C respectively). The positions of the restriction sites for
the enzymes XmaI and BsrGI are shown as black arrows, and the
expected fragment sizes indicated. (D) Restriction digest (XmaI and
BsrGI) of 12 minipreps for the two insert cloning (pX-GFP-H, lane 1 to
12) and the three insert cloning (pX-S-GFP-H, lane 13 to 24), and one
miniprep of the vector (pX-lacZ, lane V).
doi:10.1371/journal.pone.0003647.g003
Table 2. Efficiency of cloning for two or three inserts.
Experiment Construct 0 min* (white/blue) 5 min (white/blue) 10 min (white/blue) 20 min (white/blue) 30 min (white/blue)
1 insert pX-GFP 0/806 15/0 56/0 186/0 364/0
2 inserts pX-GFP-H 0/649 3/0 6/1 26/0 81/0
2 inserts pX-GFP-H 0/503 8/2 5/0 58/0 136/1
3 inserts pX-S-GFP-H 0/460 0/0 1/0 3/1 24/0
3 inserts pX-S-GFP-H 0/314 1/2 1/1 9/0 27/1
Restriction-ligations were performed from 5 to 30 minutes in Promega ligation buffer, and followed by digestion and heat inactivation. Cloning for two or three inserts
was performed in duplicate.
*The zero minute time point was performed without adding BsaI to the restriction-ligation mix.
doi:10.1371/journal.pone.0003647.t002
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gagtcatggaaagaac). Cloning was also successful (Fig 5B)
Discussion
These results show that a gene or DNA fragment of interest can
be subcloned from one entry vector to an expression vector as
easily and efficiently as when using recombination-based systems.
However, in contrast with those systems, the recombinant
plasmids obtained with our strategy do not contain a recombina-
tion site at the junction sites. In fact, the only requirement is 4
nucleotides of defined sequence at the restriction/ligation site.
This means that only one amino-acid is fixed at the ligation site (if
this region is part of translated sequences). Moreover, the sequence
of the 4 nucleotides can theoretically be freely chosen by the
experimenter since it can consist of any 4 nucleotide sequence of
choice. However, sequences to avoid for these 4 nucleotides are
the 16 palindromic sequences, which would reduce cloning
efficiency, therefore leaving a choice of 240 possible sequences
(out of 256). At present all sequences that we have tested have
performed well, but more use of this cloning strategy will reveal
whether this can be generalized for all 240 possible sequences and
for any specific combination of these.
This cloning protocol also allows cloning of at least three DNA
fragments from three separate entry clones into an acceptor
Figure 4. General strategy for generation of entry clones
lacking internal BsaI sites. For each gene of interest, two primers are
designed to introduce two BsaI flanking sites (pr1, pr2), as well as one
pair of primers for each internal site to eliminate (pr3, pr4). Column-
purified PCR products pr1–3 and pr2–4 are mixed together with entry
cloning vector (pECV) and BsaI enzyme in restriction-ligation buffer. The
mix is digested for 10 minutes and heat inactivated. Ligase is then
added and the mix is ligated for 10 minutes before transformation in
E.coli. All white colonies contain the expected entry clone, with two
flanking BsaI sites but no internal site. Horizontal arrows represent parts
of the primers identical to the target sequence. Small vertical arrows
indicate the location of the introduced mutation.
doi:10.1371/journal.pone.0003647.g004
Figure 5. Generation of entry clones lacking internal BsaI sites
for genes ycf4 and psbC. (A) Three PCR fragments were amplified
from Arabidopsis thaliana genomic (chloroplast) DNA using primers
yc1–6 (gene ycf4). B, BsaI recognition sequence. The fragments were
cloned in on tube into entry cloning vector pECV, resulting in entry
clone pE-YCF4. Structure of the fragments for the psbC gene (not
shown) is similar except that the wildtype gene contains only one
internal BsaI site. (B) Restriction digest (BsaI) of minipreps from 10 white
colonies for constructs pE-YCF4 and pE-PSBC. As a control, the ycf4 and
psbC ORFs were amplified from genomic DNA with only the two
flanking primers, and the PCR products run undigested (u, expected
size 583 nt for ycf4 and 1450 nt for psbC) and digested with BsaI (d,
expected sizes for ycf4: 332, 113, 54, 14, 10, expected sizes for psbC:
947, 469, 14, 10).
doi:10.1371/journal.pone.0003647.g005
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restriction sites in the entry clones and the acceptor vector.
As with recombination-based systems, the cloning method
described here can be used to transfer one gene of interest (or more
generally any DNA fragment of interest) from one entry clone to a
series of different expression vectors designed to have compatible
cloning sites. For example, we have made several compatible vectors
that allow expressing the same gene of interest in either viral vectors
or in standard non-replicating expression vectors (Fig 6).
One advantage of recombination-based systems is that restric-
tion enzymes can be avoided both for generation of the entry
clones, for example using the ligation-independent cloning strategy
of the In-Fusion system from Clontech, and for subcloning into
expression vectors using site-specific recombination. In contrast,
one potential limitation of the protocol presented here might come
from the occasional presence of one or several internal BsaI site(s)
in the gene of interest. Since the BsaI restriction site has a 6 base
pair recognition sequence, BsaI restriction sites are expected to be
present in average every four kb for genomes with a GC content of
50%. In practice, the restriction site frequency will of course
depend on the base composition of each specific organism. For
example, out of 86 annotated coding sequences in the Arabidopsis
thaliana chloroplast genome (GenBank NC_000932), only six
contain one BsaI site and four contain two sites. Nevertheless,
there are at least three possible solutions for bypassing this
problem. One solution consists of performing the digestion and
ligation sequentially, and heat inactivating the restriction enzyme
before performing the ligation. A variation of this solution is to
perform the restriction-ligation for 5 minutes, then heat inactivat-
ing the enzymes, then adding fresh ligase to the mix, and ligating
for another 5 to 10 minutes. We often use this strategy when the
insert to be cloned contains an internal BsaI restriction site. This is
extremely efficient since the restriction-ligation stably ligates both
insert fragments at the ends of the vector in the first step, and the
following ligation step only needs to religate a linear molecule. A
second solution would consist of using a second type IIs enzyme
(for example BpiI) to perform the cloning from entry clone to
expression vector. This would however require having a second set
of expression cloning vectors with restrictions sites for the second
type IIs enzyme, and therefore, this is not a preferred solution. The
third and more general solution consists of eliminating any BsaI
restriction site from the fragment of interest upon cloning in the
entry clone, as was shown in the results section. Elimination of the
BsaI site(s) from an entry vector requires sequencing the amplified
sequence to confirm that no PCR-derived mutation is present;
however, sequencing is also necessary for all other entry clones
since they are all made by PCR. The extra work consists only of
designing an additional pair of primers for each BsaI site to be
removed.
For the method to work, it is also necessary to remove any BsaI
restriction site in the expression vector, except for the two sites
flanking the LacZ alpha fragment (or any other negative selection
marker that an experimenter would prefer to use).
In summary, the cloning strategy described here, that we call
‘Golden Gate’ cloning, combines the convenience and efficiency of
currently used recombination-based cloning systems with unique
insert precision.
Materials and Methods
Molecular biology reagents
Restriction enzymes used in this study were purchased from
New England Biolabs. T4 DNA ligase was purchased from
Promega. Mini-plasmid DNA preparations were made by using
the NucleoSpin Plasmid Quick Pure kit (Macherey-Nagel, Du ¨ren,
Germany) following the manufacturer protocol. Plasmid DNA
concentration was measured using a Nano DropH Spectropho-
tometer ND-1000 (Peqlab, Erlangen).
Constructs
A GFP gene was flanked by BsaI restriction sites using PCR
amplification of a GFP coding sequence using primers bsgfp3 (ttt
ggtctc a aggt atggtgagcaagggcgaggag) and bsgfp2 (ttt ggtctc a aagc
Figure 6. Model for subcloning of a gene of interest into a
library of compatible expressions vectors. (A) A gene of interest
can be cloned as a single fragment in one entry construct (EC) or cloned
as separate fragments in several entry constructs (ECs). BsaI sites 1 to 4:
B1–B4. Example of three expression vectors consisting of a viral
provector (V1), a TMV-based viral vector (V2) and a standard non-
replicating expression vector (V3), and of the expression constructs
obtained after cloning (E1–3). GOI, gene of interest; pol, TVCV RNA-
dependent RNA polymerase; m, movement protein; SP, signal peptide;
P, promoter. (B) Overview of the cloning strategy from entry construct
to expression vector. Boxes flanking the LacZ fragment (blue) represent
elements specific to the various expression vectors.
doi:10.1371/journal.pone.0003647.g006
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(Promega), resulting in construct pE-GFP. The LacZ cassette and
the flanking BsaI sites present in pX-lacZ was obtained by PCR
amplification from pUC19 DNA using primers laczins3
(tttcgtctctgtcg aggt a gagacc gaattcgcagctggcacgacaggtttc) and
laczins6 (tttcgtctcttacc aagc t gagacc acggttgtgggtcacagcttgtctg-
taagcg). The plasmid backbone of pX-lacZ contains a kanamycin
resistance gene (derived from pBIN19) for selection in E.coli and
Agrobacterium and does not contain any BsaI restriction site other
than the two sites flanking the LacZ fragment. Other elements of
the constructs (attB site, viral sequences) are as described in [2].
The GFP sequences in plasmids pE-GFP3 and pE-GFP2 were
obtained by PCR amplification using primers pairs calgef3/bsgfp5
(ggtctc a tatggtgagcaagggcgaggag/ggtctc a cttgtacagctcgtccatgccg)
and bsgfp3 (ttt ggtctc a aggt atggtgagcaagggcgaggag)/bsgfp5 and
cloned in pUC19 digested with SmaI. pE-S was obtained by PCR
amplification of a Nicotiana plumbaginifolia apoplast signal peptide
from cloned sequences using primers calgef1 (ggtctc a aggtatggc-
tactcaacgaagggc) and calgef2 (ggtctc a catacctgagacgacagcgacgag)
and cloned in pUC19 digested with SmaI. pE-H was made by
cloning an adapter (ggtct cacaa gggca gcagc cacca ccacc accac
cacta agctt tgaga cc) into the SmaI site of pUC19.
Plasmid pECV was made by first amplifying a LacZ fragment
by PCR from pUC19 using primers ecv1 (ttt gaagacttgtcgggtct-
caaggtgcagctggcacgacaggtttc) and ecv2 (ttt gaagactttaccggtct-
caaagccgcgcgtttcggtgatgac). The primers introduce the BsaI
restriction site flanking the LacZ gene. This fragment is cloned
using BpiI into a vector backbone fragment amplified from
pUC19spec (pUC19spec is identical to pUC19 except that the bla
gene was replaced by a spectinomycin resistance gene, this
backbone was chosen because it does not contain an internal BsaI
restriction site) using primers bpi191 (tttt cgacaagtcttcattaat-
gaatcggccaacgcgc) and bpi192 (tttt ggtaaagtcttccgggagctgcatgtgt-
cag).
Sequencing
Sequencing was performed by GATC Biotech AG (Konstanz).
Either plasmid DNA or bacteria were sent. Sequencing of the
expression clones pX-GFP, pX-GFP-H and pX-S-GFP-H was
carried out using primer 39NTRrev (tacaccgtaagtctatctcttcg,
located downstream of the subcloned GFP gene). Clones for pE-
YCF4 were sequenced using vector primer seqf (tggaaaaacgccag-
caacgc).
Preparation of competent cells and transformation
Chemical competent DH10B cells were prepared as follows:
DH10B cells grown to an OD600 of 0.6 were centrifuged 5 min at
45006g and washed with 0.4 volumes 30 mM Potassium acetate,
10 mM CaCl2, 50 mM MnCl2, 100 mM RbCl and 15% Glycerol;
after a second centrifugation step, the pellet was resuspended in 1/
25 volume of 100 mM MOPS, 75 mM CaCl2, 10 mM RbCl,
15%Glycerol. 100 ml aliquots of cell suspension were frozen in
liquid nitrogen. For transformation, tubes containing 100 ml
aliquots were thawed on ice. The ligation (10 ml) was added to
the cells and the mix incubated on ice for 5 minutes and then heat
shocked for 1 min at 42uC. 500 ml of LB medium was added to the
transformed cells, and after 30 min incubation on a shaker at
37uC, 25 ml of this were plated on LB medium containing
kanamycin (50 mg/ml) and X-Gal (40 mg/ml).
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